Location History:
- Hampton, NJ (US) (1976 - 1979)
- St. Louis, MO (US) (1977 - 1981)
- Rehovot, IL (1982)
Company Filing History:
Years Active: 1976-1982
Title: The Innovative Contributions of Samuel S. Asculai
Introduction
Samuel S. Asculai is a notable inventor based in St. Louis, MO (US). He has made significant contributions to the field of immunology, holding a total of 7 patents. His work has advanced the understanding and application of immune responses in warm-blooded animals.
Latest Patents
Among his latest patents is a method of producing an immune response by administering a polymeric composition. This method involves administering a specific dosage of a copolymer of olefin monomer and polycarboxylic anhydride, which is derivatized to contain half-amide, half-carboxyl acid groups and imide groups. Another significant patent is the radioimmunoassay of migration inhibitory factor (MIF), which provides a method for detecting MIF in test solutions through a series of reactions involving radiolabeled antigens and antibodies.
Career Highlights
Throughout his career, Samuel S. Asculai has worked with prominent companies such as Ortho Pharmaceutical Corporation and Monsanto Company. His experience in these organizations has contributed to his expertise in the field of immunology and patent development.
Collaborations
Some of his notable coworkers include Alfred B. Kupferberg, who is deceased, and Meyer Halpern, who serves as a coexecutor. Their collaborations have likely enriched the research and development processes in which Asculai has been involved.
Conclusion
Samuel S. Asculai's innovative work and patents have made a lasting impact in the field of immunology. His contributions continue to influence research and applications in medical science.